Grifulvin V
In brief
- Grifulvin V is supplied in community pharmacies and by licensed suppliers; it is prescription-only in virtually all jurisdictions (including Australia) so you should normally present a prescription — although some online or local outlets may claim to supply it without a prescription, which is not recommended and may be illegal.
- Griseofulvin (Grifulvin V) is used to treat dermatophyte infections (tinea of the scalp, skin and nails); it works by binding to keratin and interfering with fungal mitosis/microtubule function, protecting new hair, skin and nails as they grow and preventing fungal invasion.
- Usual adult doses are 500 mg–1 g daily (often given as 500 mg twice daily or 1 g once daily depending on product); children receive 10–20 mg/kg/day (single or divided doses); nail infections often require prolonged courses, sometimes up to 12 months.
- Administered orally as tablets (125 mg, 250 mg, some regions 500 mg) or as an oral suspension (e.g. 125 mg/5 mL in some regions); take microsize tablets with a fatty meal to improve absorption.
- Clinical improvement is generally slow — visible benefit usually takes weeks (for tinea capitis often 4–6 weeks; skin infections commonly 2–4 weeks); nail infections show improvement only after months as the nail grows out.
- Duration of action depends on the course: continue daily dosing for the full treatment period (tinea capitis 4–6 weeks; tinea corporis 2–4 weeks; tinea pedis 4–8 weeks; fingernails minimum ~4 months, toenails minimum ~6 months and often longer); the antifungal effect persists only while the drug is incorporated into newly formed keratin.
- Avoid alcohol while taking griseofulvin — alcohol can increase side effects, may cause intolerance-type reactions and raises concerns about hepatotoxicity when combined with the drug.
- The most common side effects are gastrointestinal (nausea, vomiting, diarrhoea) and nervous-system symptoms such as headache, dizziness and fatigue; other effects include rash, photosensitivity and occasional liver enzyme elevations or blood dyscrasias.
- Would you like to try grifulvin v without a prescription?
Basic Grifulvin V Information
- INN (International Nonproprietary Name): Griseofulvin
- Brand Names Available In Australia: not specified
- ATC Code: D01BA01
- Forms & Dosages: Tablets 125mg, 250mg; tablets 500mg (some regions); oral suspension 125mg/5ml (some regions)
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription only (Rx) in virtually all regulatory jurisdictions
Critical Warnings & Restrictions
Who should be most careful about griseofulvin?
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
- Absolute contraindications: severe hepatic failure, porphyria, known hypersensitivity to griseofulvin or any excipient.
- Pregnancy and breastfeeding: griseofulvin is embryotoxic and teratogenic and is a relative contraindication for pregnancy and lactation.
- Advice for women: avoid use if planning pregnancy and use effective contraception during treatment and for at least one menstrual cycle after stopping.
- Elderly and chronic liver/renal disease: use with caution and monitor liver function and blood counts regularly.
Baseline screening checklist
- Baseline liver function tests (LFTs).
- Baseline full blood count (FBC).
- Pregnancy test for women of childbearing potential before starting treatment.
Monitoring schedule
- Repeat LFTs after 2–4 weeks and periodically during prolonged therapy.
- Repeat FBC during prolonged courses or if symptoms suggesting cytopenia appear.
- More frequent checks in elderly patients or those with pre-existing hepatic dysfunction.
Red-flag symptoms — stop treatment and seek urgent medical review
- Yellowing of skin or eyes (jaundice).
- Unexplained bruising or bleeding.
- Severe skin rash or blistering.
- Signs of infection with fever, sore throat or mouth ulcers (possible neutropenia).
- Severe persistent abdominal pain, dark urine or vomiting.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Griseofulvin can cause dizziness, fatigue and confusion in some people.
If these symptoms occur, they may impair driving or operation of heavy machinery.
Under Australian road safety laws you must be fit to drive and not affected by medications.
Employees in safety-sensitive roles should discuss use with their employer or occupational health service and may need temporary work adjustments.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: If you experience dizziness, drowsiness or visual disturbance, do not drive.
Australian road safety law requires you to be fit to drive, so always follow prescriber or pharmacist advice.
Usage Basics
INN, Brand Names Available In Australia
INN: Griseofulvin.
International brands include Grifulvin V, Fulvicin P/G, Gris-PEG, Griseofulvina, Griséofulvine, Griseofulvinum and Amudane.
Always confirm local TGA ARTG listings and sponsor details before procurement or substitution.
| INN | Common International Brand Examples |
|---|---|
| Griseofulvin | Grifulvin V, Fulvicin P/G, Gris-PEG, Griseofulvina, Griséofulvine, Griseofulvinum, Amudane |
Legal Classification (TGA-Approved, PBS-Listed)
Griseofulvin is generally prescription-only (Rx) in most jurisdictions.
In Australia clinicians and pharmacists should check the TGA ARTG database for current registration and the PBS for subsidy status before prescribing or dispensing.
- Step 1: Search the TGA ARTG for the product name and sponsor details.
- Step 2: Verify current approval status and indications in the ARTG entry.
- Step 3: Check PBS listings for subsidy, restrictions and prescribing rules.
- Step 4: Contact the listed sponsor for supply and availability questions.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Typical adult dosing varies by site of infection.
| Condition | Adult Dose | Paediatric Dose | Typical Duration |
|---|---|---|---|
| Tinea Capitis | 500mg–1g daily | 10–20 mg/kg/day | 4–6 weeks |
| Tinea Corporis/Cruris | 500mg–1g daily | 10–20 mg/kg/day | 2–4 weeks |
| Tinea Pedis/Manuum | 1g daily | 10–20 mg/kg/day | 4–8 weeks |
| Tinea Unguium (Onychomycosis) | 500mg–1g daily | 10–20 mg/kg/day | Fingernails ≥4 months; Toenails ≥6 months; often longer |
Adjustments For Comorbidities
Children use weight-based dosing of 10–20 mg/kg/day, either as a single dose or divided doses.
Elderly patients and those with hepatic impairment require caution and closer monitoring of LFTs.
Formal renal dose adjustments are not specified due to limited data, so consult a specialist if severe renal impairment is present.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless the next dose is due soon.
Do not double the next dose to make up for a missed one.
If multiple doses are missed during prolonged nail treatment, contact the prescriber for regimen review.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Absorption of griseofulvin is improved when taken with a fatty meal, particularly microsize formulations.
Recommend taking doses with a substantial breakfast or meal containing healthy fats to improve uptake.
- Practical tips: take with a full breakfast that may include eggs, avocado or dairy to aid absorption.
- Avoid taking on an empty stomach if gastrointestinal upset occurs.
- Alcohol has no well-documented pharmacokinetic interaction, but avoid heavy drinking because of hepatic risk and reduced tolerability.
Short checklist for patients
- Take with a fatty meal for better absorption.
- Limit alcohol while on therapy, especially with prolonged courses.
- Report persistent nausea, vomiting or new jaundice promptly.
Common Drug Conflicts
Griseofulvin is a hepatic enzyme inducer and may reduce plasma levels of many medicines.
| Drug Class | Effect | Clinical Action |
|---|---|---|
| Oral Contraceptives | Reduced efficacy | Advise alternative or additional contraception during treatment and one menstrual cycle after |
| Anticoagulants (warfarin) | Reduced anticoagulant effect | Monitor INR closely and adjust dose as needed |
| Anticonvulsants | Altered levels of anticonvulsants | Consult prescriber; consider monitoring or alternative antifungal |
| Benzodiazepines | Reduced sedative levels | Review clinical effect and adjust as required |
| Certain Antivirals | Reduced efficacy | Check interaction databases and consult specialist |
Immediate clinical actions
- Always check for interactions before supply.
- Consider alternative antifungals when interactions pose risk.
- Consult a clinical pharmacist for complex regimens.
User Reports & Trends
What do Australian patients commonly say about griseofulvin?
Patient feedback themes include tolerability issues, the long duration required for nail infections, and preference for shorter-course alternatives.
| Theme | Summary |
|---|---|
| Benefit | Effective for dermatophyte infections where tolerated |
| Common Adverse Effects | Gastrointestinal upset, headaches, photosensitivity |
| Adherence Barriers | Long nail treatment courses and monitoring needs reduce adherence |
Advice for clinicians to address concerns
- Explain expected duration clearly, especially for nail infections.
- Offer written monitoring plans for LFTs and blood counts.
- Discuss side-effect strategies, such as taking with food for GI upset and sun protection for photosensitivity.
Data sources and caveats
Common information sources include ProductReview, health forums and pharmacy consultation notes, but these reports can be biased by self-selection.
Always prioritise clinical evidence and report serious adverse events via local pharmacovigilance channels such as the TGA adverse event reporting system.
Access & Purchase Options
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
How to obtain griseofulvin in Australia via bricks-and-mortar pharmacies.
- Obtain a GP prescription for a private script or check PBS listing for subsidised access.
- Major chains can check stock and order generic griseofulvin if the product is registered with the TGA.
- Bring a current medicines list and any recent lab results when collecting the prescription.
- Ask the pharmacist about interactions, monitoring requirements and contraception advice if applicable.
Pharmacy actions checklist
- Stock check and online inventory lookup.
- Order options from wholesalers or sponsor if not in stock.
- Price enquiry and advise on generic alternatives.
Online Pharmacies And Telehealth E-Prescriptions
Many Australian pharmacies accept e-prescriptions issued via telehealth consultations and will post to rural addresses.
| In-Store | Online |
|---|---|
| Immediate counselling and same-day supply where stocked | Convenient for rural patients; allow extra time for shipping |
| Can arrange baseline tests locally and provide face-to-face monitoring advice | Good for repeat prescriptions and discreet delivery |
Use accredited Australian pharmacies and verify ARTG/TGA registration of products when ordering online.
Purchase note: In our online pharmacy, grifulvin v is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism & Pharmacology
Simplified Explanation
- Mechanism: griseofulvin binds to keratin in skin, hair and nails, protecting new tissue from fungal invasion.
- Target Organisms: effective against dermatophytes but not Candida or bacterial pathogens.
- Clinical Effect: fungistatic action that requires replacement of infected keratin as tissues grow.
Clinical Terms
- Oral absorption is improved with a fatty meal, especially for microsize tablets.
- Hepatic metabolism with potential for enzyme induction and numerous drug interactions.
- Prolonged therapy is required for nail and scalp infections due to slow keratin turnover.
Indications & Off-Label Uses
Approved Indications By TGA
Typical approved uses internationally and in common practice include systemic treatment of dermatophytoses.
- Tinea capitis — usual duration 4–6 weeks.
- Tinea corporis and cruris — usual duration 2–4 weeks.
- Tinea pedis/manuum — usual duration 4–8 weeks.
- Tinea unguium (onychomycosis) — prolonged courses; fingernails minimum 4 months and toenails minimum 6 months.
Confirm TGA-approved indications locally before prescribing.
Off-Label Uses In Australian Clinical Practice
Off-label use is rare and typically reserved for recalcitrant dermatophyte infections when first-line agents are unsuitable.
- Obtain specialist consultation for off-label prescribing.
- Document rationale, informed consent and enhanced monitoring in the clinical record.
Key Clinical Findings
What recent practice trends say about griseofulvin.
- Recent international practice trends (2022–2026) favour terbinafine and azoles for many dermatophyte infections because of shorter courses and higher nail cure rates.
- New clinical trials focused specifically on griseofulvin are limited in recent years.
- Clinicians should consult up-to-date national therapeutic guidelines and state health bulletins when deciding therapy.
Clinical takeaways
- Griseofulvin remains a useful option for dermatophyte infections where indicated and tolerated.
- Comparative disadvantages include longer duration for nails and higher monitoring burden compared with some alternatives.
- Monitoring needs include baseline and periodic LFTs and FBC during prolonged therapy.
Alternatives Matrix
PBS-Listed Alternatives Comparison Table
| Medicine | PBS Subsidy Status | Typical Course Length | Nail Efficacy | Major Safety Concerns |
|---|---|---|---|---|
| Terbinafine | Often PBS-listed for specific indications (check PBS) | Shorter courses (oral usually 2–6 weeks depending on site) | Higher cure rates for onychomycosis | Hepatic risk; monitor LFTs |
| Itraconazole | PBS-listed for some indications (check PBS) | Pulse or continuous regimens for nails | Good nail efficacy | Hepatic risk, many interactions |
| Fluconazole | PBS-listed for some uses (check PBS) | Variable; often weekly dosing for nails | Moderate efficacy for some dermatophytes | Hepatic risk, drug interactions |
| Griseofulvin | Check ARTG/PBS for local listing | Prolonged courses for nails, weeks for skin/scalp | Lower nail cure compared with terbinafine/itraconazole | Hepatic risk, photosensitivity, interactions |
Pros And Cons Checklist
- Indication and site of infection determine first-line choice.
- Consider patient age and pregnancy status before selecting an oral antifungal.
- Assess hepatic function and drug interaction potential when choosing therapy.
- Factor in PBS access and cost sensitivity when advising patients.
Common Questions From Australian Pharmacy Consultations
- How long until my nail looks better? — Nail growth is slow; expect fingernail improvement after at least 4 months and toenail after 6 months or longer.
- Do I need to use contraception? — Yes, effective contraception is advised during treatment and for at least one menstrual cycle after stopping.
- What side effects should I watch for? — Report jaundice, severe rash, signs of infection, persistent GI upset or new bruising.
- What monitoring is required? — Baseline LFTs and FBC, repeat LFTs during prolonged therapy and as clinically indicated.
- When should I stop and seek help? — Stop and seek urgent review for jaundice, severe rash, fever with sore throat or bleeding tendencies.
Referral triggers for pharmacists
- Severe or progressive rash, suspected drug hypersensitivity.
- Marked LFT elevations or signs of hepatic dysfunction.
- Suspected neutropenia signs such as fever and sore throat.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Supplier | In-Store / Online | Typical Price (Private Script) | PBS Subsidised | Notes |
|---|---|---|---|---|
| Chemist Warehouse | In-Store / Online | Varies by generic supplier | Check PBS | Can order generics if ARTG-registered |
| Priceline | In-Store / Online | Varies by supplier | Check PBS | Pharmacist counselling available |
| TerryWhite Chemmart | In-Store / Online | Varies by supplier | Check PBS | Ask about ordering and monitoring support |
Price-sensitive advice
- Compare prices across chains and ask for generic options.
- Check if PBS subsidy applies to reduce out-of-pocket cost.
- Rural patients should ask about mail delivery and allow extra time for supply.
Registration & Regulation
TGA Approval
Always verify ARTG entry and sponsor details in the TGA database before prescribing or importing griseofulvin products.
Regulatory status varies internationally and products may be delisted in some regions.
- Check ARTG number, product sponsor and current registration status.
- Ensure labelling and storage instructions comply with TGA requirements if importing.
- Document supplier and batch details for pharmacovigilance purposes.
PBS Subsidy Details
If griseofulvin is not listed on PBS for a patient’s indication, advise on likely out-of-pocket costs.
- Where PBS listing exists, adhere to restriction criteria and prescribing rules.
- Concessional patients may need to provide concession card details for subsidy.
- Keep copies of prescriptions and relevant clinical justification if specialist approvals are required.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store griseofulvin between 20–25°C in a dry place and protect from moisture.
Avoid storing in bathrooms or cars where heat and humidity are common.
- Keep medication in the original container with the label intact.
- Keep out of reach of children and pets.
- Return unused medicine to a pharmacy for safe disposal.
Cold-Chain Handling For Pharmacies
Griseofulvin does not require cold-chain storage but avoid extremes of heat.
- Transport in standard pharmacy shipping with temperature control if exposed to high heat.
- Check expiry dates and storage instructions on bottles and blister packs when receiving stock.
- Rotate stock using first-expiry-first-out principles.
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Use a structured counselling script to ensure safety and adherence.
- Indication: explain what infection is being treated and expected outcomes.
- Dose & duration: state the exact daily dose and total duration, emphasising long courses for nails.
- Administration: take with a fatty meal to improve absorption.
- Contraception: advise effective contraception during treatment and for one menstrual cycle after stopping.
- Monitoring: arrange baseline LFTs and FBC and schedule follow-up tests for prolonged therapy.
- Side effects: advise on GI side effects, photosensitivity and red-flag symptoms to report.
- Driving/work safety: warn about possible dizziness and the need to avoid safety-sensitive tasks if affected.
- Missed dose: simple instruction — take when remembered unless close to next dose; do not double up.
Printable patient checklist items
- Start date, dose and stop/review date.
- Dates for baseline and follow-up LFT/FBC.
- Emergency contact and referral pathway if severe reaction occurs.
Patient Advice From PBS And National Health Authorities
Give patients a written plan with monitoring dates and contact details for adverse events.
Encourage reporting of adverse events via the TGA adverse event reporting system.
- Provide referrals to dermatology, paediatrics or obstetrics as needed.
- Keep a copy of the prescription and any test results for follow-up consultations.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Sunshine Coast | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
Final Notes
Griseofulvin remains a recognised systemic antifungal for dermatophyte infections with a long history of use.
Pick the antifungal taking into account site of infection, expected duration, pregnancy plans and drug interaction potential.
For many nail infections, terbinafine or itraconazole may be preferred due to shorter regimens and higher cure rates, but griseofulvin remains an option where appropriate.
Always check current TGA ARTG and PBS entries before prescribing or dispensing and document monitoring plans clearly in the patient record.